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To provide the review of the macrophage activity products as pathophysiological markers
of endometriosis by literature survey (PubMed, Cochrane). Immunoreactive cells and
several of their synthesis products concentrations are elevated in the serum and peritoneal
ﬂuid in patients with endometriosis. The enhanced reactive proteins contributed to local
inﬂammation and aggregation of endometriotic lesions. Immune response and immune
surveillance of tissue play an important role in pathogenesis of endometriosis. Activated
macrophages in peritoneal environment secrete immunoreactive cytokines which are
responsible for inﬂammatory cascade of reactions. The immunoreactive cytokines should
be a target not only as a disease marker but also as a part of therapeutic protocol.1. Introduction
Endometriosis is characterized by hormone depending
persistence and growth of endometrial tissue at ectopic sites,
mostly pelvic peritoneum and organs: ovaries, rectum, urinary
bladder. It affects 10%–15% of women of reproductive age and
is associated with pelvic pain, dysmenorrhea, dyspareunia and
infertility. Despite the fact that it is considered as one of the most
frequently encountered gynecological disorders, the pathogen-
esis of endometriosis still remains poorly understood.
Four most popular theories were proposed to explain the
pathogenesis and pathophysiology of endometriosis. However,
none of them can particularly explore all the determining factors.
In 1927, Sampson postulated the retrograde menstruation
theory, according to which the endometrial shed elements could
pass along the fallopian tubes and reach the peritoneal cavity[1].
Considering the gravity, the menstruation blood would thus
reach, especially the ovaries, the Douglas pouch, uterosacral
ligaments, rectum and urinary bladder. Another popular
etiological theory of endometriosis is the celomic metaplasia.
The fact of metaplasia of undifferentiated tissue could possibly
explain the existence of endometriosis in distant sites.
Dinelescu et al. came up with the hypothesis that activation ofK-ras gene may be responsible for the metaplastic process[2].
There is also a hypothesis that the remnants of Mullerian
ducts could be responsible for the etiology of the disease.
Nevertheless, nowadays it is considered as highly improbable.
In order to explain the distant location of endometriosis,
Halban postulated the theory of lymph and blood
dissemination of endometrial cells[3]. According to this idea,
the endometrial cells would spread around the organism
through the lymph or blood vessel microclots. In 1987,
Gleicher et al. postulated that endometriosis could be an
autoimmune disease considering the presence of certain
autoantibodies in serum[4]. In the study of Barrier, it was not
proved that there was any correlation between co-occurrence
of endometriosis and immune-mediated polyarthritis, Sjogrens
syndrome or systemic lupus erythematous[5]. Several studies
accentuated the role of race, uterine obstruction, life conditions
in the pathogenesis of endometriosis[5,6]. Currently, more data
support the immunological theory of endometriosis, according
to which it is an inﬂammatory disorder recruiting cellular and
humoral factors.
The aim of the present study is to review the literature for
novel proinﬂammatory markers of endometriosis.
2. Materials and methods
Comprehensive searches in PubMed and Cochrane databases
were conducted to identify studies published between 1995 and
2014 in English language with keywords: “macrophages”,
“endometriosis”, “interleukins”, “tumor necrosis factor (TNF)”.d.
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of all articles to exclude citations deemed irrelevant were
performed.
3. Macrophages in endometriosis
Numerous studies have shown that macrophages are the most
crucial inﬂammatory cells. The peritoneal ﬂuid which normally
appears in peritoneal cavity in the volume of 5–20 mL contains
activated macrophages which determine and sustain the
inﬂammation. Macrophages are an integral part of mononuclear
phagocyte system which derives from bone marrow. After
reaching the peritoneum macrophages remain in the peritoneal
cavity as dendritic cells or scavenger macrophages. Among the
macrophages exists a classical/inﬂammatory M1 population
characterized with the antigen cytotoxicity, synthetizing cyto-
kines like interleukin-12 (Il-12), and modulating ROS and nitric
oxide factors. The M2 population of macrophages is responsible
for enhancing the inﬂammatory response and also for the tissue
reparation. During the acute stage of endometriosis, an
increasing number of activated macrophages in the peritoneal
ﬂuid and endometriotic implants is observed. Those activated
macrophages are responsible for numerous growth factors while
cytokines secretion responsible for proliferation, angiogenesis,
inﬂammatory response and clinical manifestation of the
disease[7,8].
3.1. Interleukin-1
Among the secretory products of activated macrophages,
interleukin-1 is an important immunomodulatory factor. Il-1 is
the name standing for a group of molecules which induce the
inﬂammation pathway and are responsible for the pro-
inﬂammatory mechanisms. Among the Il-1 family, there are Il-
1a and Il-1b which together with antagonist receptor (Il-1Ra)
cooperate in responding to inﬂammation signals[9,10]. IL-1a and
IL-1b bind to the same receptor molecule. The third ligand of
this receptor (Il-1r), the interleukin 1 receptor antagonist (IL-
1Ra), acts as an inhibitor of IL-1a and IL-1b signaling by
competing with them for binding sites of the receptor. The
most popularly known initializing factors for producing Il-1
are lipopolysaccharides (the component of bacterial wall) and
the C5-complex system[9]. The immunological role of Il-1 is to
stimulate macrophages for the synthesis of Il-2 with the receptor
(Il-2R) and Il-6. The nature killer cells cytotoxicity is enhanced
by Il-1, and lymphocyte T is enhanced for the synthesis of
interferon g. By humoral immune response, Il-1b is stimulating
B lymphocytes for producing antibodies. Increasing concentra-
tion of Il-1 in the inﬂammation area is a chemoattractive factor
for monocytes and neutrophils. These cytokines increase the
expression of adhesional factors ICAM-1, VCAM-1 and selectin
E on endothelial cells, to enable transmigration of immuno-
competent cells, such as phagocytes, lymphocytes and others, to
sites of infection. The new colonies of monocytes are recruited
due to the production of M-CSF, GM-CSF and G-CSF. Vigano
et al. suggested that Il-1b stimulated ICAM-1 dependent im-
mune surveillance of shed endometrial cells in the peritoneal
ﬂuid environment. The Il-1 also affects the activity of the hy-
pothalamus which leads to a rise in body temperature. That is
why Il-1 is called an endogenous pyrogen. IL-1 also causes
hyperalgesia. These are some frequent clinical symptomscorrelated with the menstrual bleeding in the patients diagnosed
with endometriosis. They often present the peritonitis symptoms
which can be incorrectly interpreted as appendicitis, extrauterine
pregnancy, diverticulitis, etc[5,9,11].
3.2. Interleukin-6
In endometriosis, macrophages produce signiﬁcantly higher
levels of Interleukin-6[12]. This is both a pro-inﬂammatory
cytokine and an anti-inﬂammatory myokine, encoded by IL-6
gene. IL-6 is secreted by T cells and macrophages, in response
to Il-1 stimulation (in the positive feedback) and interferones,
lipopolysaccharides or TNF. Osteoblasts secrete IL-6 to stimu-
late osteoclast formation. Smooth muscle cells in the tunica
media of many blood vessels also produce IL-6 as a pro-
inﬂammatory cytokine. As an anti-inﬂammatory cytokine, IL-6
is mediated through its inhibitory effects on TNF-a and IL-1.
The biological activities of Il-6 are mediated by the Il-6 recep-
tor-system which comprises two membrane proteins, the ligand
bindinga subunit (Il-6 R) and the signal transducing b subunit,
gp130. Il-6 is an essential cytokine for differentiation of B
lymphocytes into antibodies-producing cells and contributes to
production of immune complexes in endometrial stromal tis-
sue[12,13]. In co-operation with Il-1, this cytokine promotes the
production of T cells. It also applies to have an angiogenic
potential (connected to Il-3) which affects the uncontrolled
growth and invasion of adjacent tissue. This phenomenon of
macrophage activation products enforces vascularization and
angiogenic potential which is responsible for the new endome-
trial lesions and widespreading of the disease[6,14]. Concerning
endometriosis in the context of autoimmune diseases, Il-6 is a
promoting factor for the epithelial and mesangial tissue growth
so that it could be responsible for lacking of autoimmunology
response of the organism. IL-6 is also an important mediator of
fever and acute phase response. It is capable of crossing the
blood–brain barrier and initiating synthesis of PGE2 in the hy-
pothalamus. Endometrial stromal and epithelial cells produce Il-
6 in response to hormonal and immunological activity. Il-1a and
b, TNF, interferon-g stimulates the endometrial cell protein Il-6.
It is suggested that estrogen stimulates the endometrial cell
proliferation by inhibiting the production of Il-6 (which is
considered to be epithelial cell inhibitor). Barrier proposed that
endometriotic implants were resistant to Il-6 activity due to a
low expression of Il-6R on the cell surface[5]. There is no
consensus between studies about the concentration of Il-6 in
the peritoneal ﬂuid.
3.3. Interleukin-8
Interleukin 8 is a chemokine and chemo attractant produced
by macrophages. The oxidative stress correlated with local im-
munodeﬁciency is a triggering factor for releasing the levels of
Il-8 (also named as CCX-8, chemokine 8). Il-8 not only induces
the migration of neutrophils to the inﬂammation area, but also is
responsible for phagocytosis, increase of intracellular calcium
concentration and exocytosis. However, since years, many
studies have postulated that Il-8 is also an angiogenic factor for
the cells[15,16]. Excessive neovascularization and angiogenesis are
responsible for the recruitment of a new endometriotic lesions
and immune surveillance of existing one. In the clinical
practice by laparoscopic views, it is always noticeable that
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Go´mez-Torres et al. explained this fact by the local secretion of
Il-8 which stimulates the adhesion of stromal endometrial cells
by ﬁbronectin[17]. Many observations have proved the elevated
levels of Il-8 both in peritoneal ﬂuid and sera in patients with
endometriosis. Nevertheless, there is no compromise whether Il-
8 is stimulating not only deep ovarian endometriosis (seen with
the endometrial cysts) but also endometriotic lesions. By Gaz-
vani et al., there was signiﬁcantly high correlation between the
Il-8 concentration and angiogenic pathophysiology, while Barcz
and coworkers showed no connection between endometriosis
and Il-8 level in serum and peritoneal ﬂuid[15,16].
3.4. Interleukin-12
There are several studies considering interleukin-12 as an
important pathophysiological factor in etiology of endometri-
osis. IL-12 is a heterodimeric cytokine encoded by two separate
genes, p35 and p40. It is naturally produced by macrophages,
dendritic cells and B lymphocytes in response to antigen stim-
ulation. IL-12 is involved in the differentiation of T cells into
Th1. It stimulates the production of interferon gamma (IFN-g)
and TNF-a by macrophages in autocrine mechanism. It also
stimulates the production of NK cells and inhibits the immu-
nosuppressive activity of Il-4. IL-12 also has an antiangiogenic
activity due to IFN-g synthesis which stimulates the inducible
protein-10. IL-12 binds to the IL-12 receptor, which is a heter-
odimeric receptor formed by Il-12Rb1 and IL-12Rb2. IL-12R-
b2 is considered to play a key role in IL-12 function. In the
context of immunodeﬁciency deﬁnition, several studies were
conducted to determine the role of Il-12 in pathogenesis of
endometriosis. Gazvani and colleagues postulated that this
cytokine was a standard constituent of peritoneal ﬂuid in women
with endometriosis. In their study, there was no correlation be-
tween stage, clinical symptoms, cycle phase or the concentration
of Il-12 in the peritoneal ﬂuid[16,18,19].
On the other hand, in the study of investigators led by Itoh,
the immunoregulatory role of Il-12 in pathogenesis of endo-
metriosis was strongly fostered. They enhanced the cytotoxic
effect of the cytokine to nature killer cells and Th1 lymphocytes
by adding Il-12 to cultured cells[19]. The local increase of
immunological activity in peritoneal cavity attenuates the
adhesional potential of endometrial stromal cells[20]. In fact,
patients with the low Il-12 concentration in the peritoneal ﬂuid
are potentially more susceptible to development of endometrial
superﬁcial cells and deep endometriotic lesions.
3.5. TNF-a
Many studies indicate that some of the main endometriosis
symptoms like pelvic pain, infertility, dysmenorrhea, are the
effect of TNF-a activity. TNFs are the family of pleiotropic
cytokines with a range of injurious effects. TNF-a is produced
by macrophages, monocytes, neutrophils and activated lym-
phocytes. The immunomodulatory role of TNF-a is up to the
receptors TNF-R1 and TNF-R2 located at the surface of immune
cells[21]. The activity and functioning of TNF-a is strongly
correlated with and enhanced by Il-1 and Il-6. The main activ-
ities are stimulating the inﬂammatory response (production of
stress reactive oxidants, prostaglandin E2) and phagocytosis and
chemoattractant for neutrophil cells. TNF-a is also known as apyrogen and stimulator of an acute phase response markers, such
as C-reactive protein, ﬁbrinogen, myoglobin. In the studies of
Braun et al., it was proved that TNF-a was a physiological
cytokine present in human in both proliferative-phase and
secretory-phase endometrium. The immunoreactive TNF-a
which is additionally enhanced by Il-1 and progesterone has a
strong effect to induce the inﬂammatory reaction as well as the
adhesion of endometrial cells to a stroma of peritoneal cavity[22].
Gogacz and colleagues have indicated that concentration of
activated macrophages producing TNF-a in the peritoneal
ﬂuid of patients with endometriosis is signiﬁcantly higher than
in a control groups[13]. Moreover, some scientiﬁc data have
postulated that there is a correlation between the elevated
concentration of TNF-a in peritoneal environment and the
stage of endometriosis[23].
4. Conclusions
The peritoneal immune cells are the source of TNF-a and
concomitantly they play an important role in pathogenesis of
endometriosis. Clinical studies supporting the inﬂammatory
response in pathogenesis of endometriosis still remain hypo-
thetical and demand to be conducted. Not only many of the
clinical symptoms like pelvic pain, infertility, dysmenorrhea and
dyspareunia but also the laboratory tests, elevated C-reactive
protein, Ca-125, ROMA and elevated white blood cells levels,
seem to strongly support this theory. It seems that activated
macrophages in the local peritoneal environment and their
immunoreactive cytokine products are the etiological factors of
the inﬂammatory pathway but also of the adhesional and inﬁl-
tration potential of endometrial stromal cells. Elevated cytokines
concentration in the serum and peritoneal ﬂuid could be a dis-
ease marker and the prediction factor of staging and prognosis of
endometriosis. Future diagnostic and treatment strategies should
consider these immunoreactive markers in order to establish
more precise diagnostic protocol and implicate new therapeutic
strategies.
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